featured
DOAC vs Low–Molecular Weight Heparin for Treatment of VTE in Cancer Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Thrombosis Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Direct Oral Anticoagulant Versus Low-Molecular-Weight Heparin for Treatment of Venous Thromboembolism in Cancer Patients: An Updated Meta-Analysis of Randomized Controlled Trials
Thromb. Res. 2020 Oct 01;194(0)57-65, T Haykal, Y Zayed, S Deliwala, J Kerbage, A Ponnapalli, S Malladi, S Goranta, V Samji, S AdamFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.